According to a national survey of doctors published in The New England Journal of Medicine, 94% of physicians have "a relationship" with the pharmaceutical, medical device or related industries. A research firm recently estimated that drug companies spend over $20 billion annually marketing directly to physicians. With statistics like these, it is not surprising that the public is becoming concerned that these ties may influence how medications are developed, marketed and prescribed.
- June 22, 2010Kevin M. Quinley
Last month, the author began discussion of the importance of conducting discovery on damages in the early stages of case preparation. The discussion concludes herein.
May 26, 2010Chad L. StallerThere is a very important distinction between evidence that a particular complication is a risk of a procedure, and evidence that this complication occurs without negligence. Evidence of the former is not relevant without the latter.
May 26, 2010Christopher D. BernardIn a landmark holding released May 3, the U.S. Supreme Court held that the Public Health Service Act (PHSA) precludes Bivens-type actions against U.S. Public Health Service (PHS) personnel for constitutional violations arising out of the performance of their official duties.
May 26, 2010Janice G. Inman
